Chinese Standards Shop Partner of Google-Books Database: 169759 (Nov 10, 2019)
 HOME   Quotation   Tax   Examples Standard-List   Contact-Us   View-Cart
  

YY/T 1192-2011

Chinese Standard: 'YY/T 1192-2011'
Standard IDContents [version]USDSTEP2[PDF] delivered inStandard Title (Description)StatusRelated Standard
YY/T 1192-2011English170 Add to Cart 0--15 minutes. Auto immediate delivery. Human chorionic gonadotropin (HCG) quantitative detection reagent (kit) (Chemiluminescent immunoassay) Valid YY/T 1192-2011
YY/T 1192-2011Chinese14 Add to Cart <=1-day [PDF from Chinese Authority, or Standard Committee, or Publishing House]

 YY/T 1192-2011 -- Click to view a PDF In 0~10 minutes time, full copy of this English-PDF will be auto-immediately delivered to your email by our cloud-server.  
Detail Information of YY/T 1192-2011; YY/T1192-2011
Description (Translated English): Human chorionic gonadotropin (HCG) quantitative detection reagent (kit) (Chemiluminescent immunoassay)
Sector / Industry: Medical Device & Pharmaceutical Industry Standard (Recommended)
Classification of Chinese Standard: C44
Classification of International Standard: 11.100
Word Count Estimation: 9,954
Date of Issue: 2011-12-31
Date of Implementation: 2013-06-01
Quoted Standard: GB/T 21415-2008
Drafting Organization: Beijing Medical Device Testing
Administrative Organization: National Standardization Technical Committee of Medical clinical testing laboratories and in vitro diagnostic systems
Regulation (derived from): State Food and Drug Administration Notice 2011 No. 106; industry standard filing Notice 2013 No. 6 (No. 162 overall)
Proposing organization: State Food and Drug Administration
Issuing agency(ies): China Food and Drug Administration
Summary: This standard specifies the shock cord human chorionic gonadotropin (HCG) quantitative assay (box) (chemiluminescent immunoassay) classification, requirements, test methods, marking, labeling, instructions, packaging, transportation and storage. This standard applies to the principle of chemiluminescence immunoassay for the quantitative detection of human blood or other body fluids matrix components of human chorionic gonadotropin shock cord (HCG) reagent (box) [The following tube called "HCG reagent (box)"]. Including microplates, tubes, magnetic particles, beads and plastic beads, etc. as the carrier of enzymatic and non-enzymatic chemiluminescence immunoassay reagent (box). This standard does not apply to: a) intended for human chorionic gonadotropin sold separately calibrators and control materials of human chorionic gonadotropin, b) to chemiluminescent immunoassay for the principle of bio-chips.

YY/T 1192-2011 
YY
ICS 11.100
C 44
INDUSTRY STANDARD
OF THE PEOPLE’S REPUBLIC OF CHINA
Human chorionic gonadotropin (HCG) quantitative
detection reagent (kit) (chemiluminescent immunoassay)
人绒毛膜促性腺激素(HCG)定量测定
试剂(盒)(化学发光免疫分析法)
ISSUED ON. DECEMBER 31, 2011
IMPLEMENTED ON. JUNE 1, 2013
Issued by. State Food and Drug Administration
Table of Contents
Foreword ... 3 
1  Scope ... 4 
2  Normative references ... 4 
3  Classification ... 4 
4  Technical requirements ... 5 
5  Test methods ... 6 
6  Marks, labels and instructions ... 9 
7  Packaging, transportation and storage ... 11 
Bibliography ... 12 
Foreword 
This standard was drafted in accordance with the rules specified in GB/T 1.1-2009.
Please note that some contents in this document may involve patents. The issuing
organization of this document does not bear the responsibility to identify these patents.
This standard was proposed by the China Food and Drug Administration.
This standard shall be centralized by the China Clinical Laboratory Testing and In Vitro
Diagnostic Test System of Standardization Administration of China (SAC/TC 136).
Drafting organization of this standard. Beijing Institute of Medical Device Testing, Beijing
Yuande Medical Engineering Co., Ltd., Beijing Chemclin Biotech Co., Ltd., Roche
Diagnostic Products (Shanghai) Co., Ltd., and Zhengzhou Autobio Lv Ke Bioengineering
Co., Ltd.
The main drafters of this standard. Wang Ruixia, Tang Lei, Cheng Yinghao, Cai Xiaorong,
and Li Xiaoxia.
Human chorionic gonadotropin (HCG) quantitative
detection reagent (kit) (chemiluminescent
immunoassay)
1  Scope 
This standard specifies the classification, requirements, test method, marks, labels,
instructions, packaging, transportation and storage etc. of the human chorionic
gonadotropin quantitative detection reagent (kit) (chemiluminescent immunoassay).
This standard is applicable to the quantitative detection of human chorionic gonadotropin
(HCG) reagent (kit) [hereinafter referred as “HCG reagent (kit)”] of the human blood matrix
or other body fluid components, based on the principle of chemiluminescent immunoassay.
It includes the enzymatic and non-enzymatic chemiluminescent immunoassay detection
reagent (kit) in the carrier of microplates, pipes, magnetic particles, microbeads and
plastic beads.
This standard does not apply to.
a) The calibrators and quality-control materials of human chorionic gonadotropin that
are intended for separate sale;
b) The biochip that uses chemiluminescent immunoassayas the principle.
2  Normative references 
The articles contained in the following documents have become part of this document
when they are quoted herein. For the dated documents so quoted, all the modifications
(Including all corrections) or revisions made thereafter shall be applicable to this
document.
GB/T 21415-2008 In vitro diagnostic medical devices - Measurement of quantities in
biological samples - Metrological traceability of values assigned to calibrators and
control materials
3  Classification 
HCG reagent (kit) can be divided into enzymatic and non-enzymatic chemiluminescent
immunoassay reagents (kits) according to different principle of chemiluminescence.
According to different solid-phase carriers, it can be divided into the chemiluminescent
a) Product names and packaging specifications;
b) Name, address, contact information of manufacturers or after-sales service
organization;
c) Medical device registration certificate number;
d) Product standard number;
e) Product batch number;
f) Expiration date;
g) Storage conditions.
6.2 Marks and labels of each component package of reagent (kit)
It shall contain at least the following contents.
a) Product name and packaging specifications;
b) Name or trademarks of the manufacturers;
c) Product batch number;
d) Expiration date;
e) Storage conditions.
6.3 Instructions of reagent (kit)
It shall contain at least the following contents.
a) Product name;
b) Packaging specifications;
c) Intended use;
d) Detection principle;
e) Main compositions;
f) Storage conditions and expiration date;
g) Applicable instrument;
h) Sample requirement;
i) Detection method;
j) Reference value (Reference range);
k) Explanation of the detection result;
l) The limitations of detection methods;
m) Product performance index.
n) Instructions for analytical interference (hemolysis, lipemia, jaundice, etc.);
o) Instructions for specificity analysis (cross-reactants);
p) Precautions;
q) References;
r) Name, address, contact information of manufacturers or after-sales service
organization;
s) License number of medical device manufacturing enterprise (limited to domestic
enterprises);
t) Medical device registration certificate number;
u) Product standard number;
v) Approval and modified date of instructions.
7  Packaging, transportation and storage 
7.1 Package
Reagent (kit) shall be packaged according to the requirements of the manufacturing
enterprise.
7.2 Transportation
Reagent (kit) shall be transported according to the requirements of the manufacturing
enterprise.
7.3 St......
Related standard:   YY/T 1196-2013  YY/T 1197-2013
   
 
Privacy   ···   Product Quality   ···   About Us   ···   Refund Policy   ···   Fair Trading   ···   Quick Response
Field Test Asia Limited | Taxed in Singapore: 201302277C | Copyright 2012-2019